GlassScriptPhysician profile
Yee Lee Vang
NPI 1952969388
$3,984.73
in general payments reported to CMS, 2019-2025
34 companies · $195 in 2025
The $195 reported for 2025 was more than what a typical Family provider received nationally (typical 2025 total: $167).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2021: $1,521 · 2022: $1,307 · 2023: $289 · 2024: $673 · 2025: $195.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $1,157.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $1,156.95 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Glaxosmithkline, LLC. | $572.24 | 2021-2025 | Shingrix, Arexvy, Bexsero |
| Abbvie INC. | $556.69 | 2021-2024 | |
| Edwards Lifesciences Corporation | $486.21 | 2023-2024 | Sapien 3 Ultra Resilia, Evoque, Pascal |
| Boehringer Ingelheim Pharmaceuticals, INC. | $260.71 | 2021-2022 | |
| Novo Nordisk INC | $249.59 | 2021-2022 | |
| Janssen Pharmaceuticals, INC | $236.26 | 2021-2022 | |
| Lilly USA, LLC | $193.42 | 2021-2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $172.81 | 2021-2022 | |
| Merck Sharp & Dohme LLC | $129.47 | 2021-2023 | Belsomra, Januvia |
| Salix Pharmaceuticals, A Division of Bausch Health US, LLC | $119.86 | 2025 | Xifaxan |
| Eisai INC. | $113.44 | 2021-2022 | |
| Ironshore Pharmaceuticals INC. | $103.16 | 2022 | |
| Novartis Pharmaceuticals Corporation | $75.08 | 2022-2023 | |
| Biohaven Pharmaceutical Holding Company LTD. | $66.33 | 2022 | |
| Shockwave Medical, INC | $59.02 | 2024 | Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave E8 Peripher, Shockwave Intravascular Lithotripsy (Ivl) System With The Shockwave M5+ |
Show all 34 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Vanda Pharmaceuticals INC. | $50.61 | 2022 | |
| Therapeuticsmd, INC. | $46.21 | 2021 | |
| Ibsa Pharma INC. | $46.10 | 2021-2022 | |
| Horizon Therapeutics Plc | $44.59 | 2021 | |
| Takeda Pharmaceuticals U.S.A., INC. | $43.29 | 2021-2022 | |
| Upsher-Smith Laboratories LLC | $41.51 | 2021 | |
| Boston Scientific Corporation | $39.94 | 2021 | |
| Esperion Therapeutics, INC. | $37.94 | 2021 | |
| Abbott Laboratories | $37.42 | 2023-2024 | Freestyle Libre 2 |
| Biohaven Pharmaceuticals, INC. | $33.65 | 2021 | |
| Hologic Sales and Service, LLC | $33.61 | 2021-2023 | Aptima |
| Sanofi-Aventis U.S. LLC | $25.11 | 2021 | |
| Astrazeneca Pharmaceuticals LP | $19.99 | 2021 | |
| Teva Pharmaceuticals USA, INC. | $19.39 | 2021 | |
| Nevro Corp. | $18.10 | 2022 | |
| Arbor Pharmaceuticals, INC. | $14.69 | 2021 | |
| Medtronic, INC. | $13.12 | 2022 | |
| Corcept Therapeutics | $12.60 | 2021 | |
| Aquestive Therapeutics, INC. | $12.57 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Yee Vang listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.